Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in MBX — MBX Biosciences, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in MBX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,472,956
+$1,189,770 QoQ
Shares Held
26,684
+181.3% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 172 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MBX Over Time

Shares Held

Position Value (USD)

Derivatives in MBX

reported options exposure · as of Jun 30, 2026
CallValue
$5,210,880
CallShares
94,400
PutValue
$1,711,200
PutShares
31,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,653,301,875 across 349 Biotechnology names. MBX ranks #104 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MBX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,711,200 31,000
2026-06-30 $1,472,956 26,684
2026-06-30 $5,210,880 94,400
2026-03-31 $283,186 9,487
2026-03-31 $2,773,065 92,900
2025-12-31 $7,191,120 228,000
2025-12-31 $2,413,693 76,528
2025-12-31 $1,573,846 49,900
2025-09-30 $3,556,000 203,200
2025-09-30 $8,519,000 486,800
2025-06-30 $257,866 22,600
2025-06-30 $315,281 27,632
2025-06-30 $645,806 56,600
2025-03-31 $100,810 13,660